SMAD2 and leukemia: We recently demonstrated a direct phosphorylation of AKT and SMAD2 via the TRPM7 kinase, influencing downstream signaling in murine and human immune and leukemia cells, respectively (Romagnani et al, 2017; Nadolni et al, 2020; Hoeger et al, 2023).